EDITORIALS

MYCN Expression in Neuroblastoma: A Mixed Message?

Katherine K. Matthay

JCO Nov 1 2000: 3591–3594. [Full Text] [PDF]

RAPID PUBLICATIONS
	Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer
	Eric J. Small, Mark W. Frohlich, Robert Bok, Katsuto Shinohara, Gary Grossfeld, Zinovi Rozenblat, Wm. Kevin Kelly, Michele Corry, and David M. Reese
	JCO Nov 1 2000: 3595–3603. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
	Susan L. Cohn, Wendy B. London, Donghui Huang, Howard M. Katzenstein, Helen R. Salwen, Todd Reinhart, Janice Madafiglio, Glenn M. Marshall, Murray D. Norris, and Michelle Haber
	JCO Nov 1 2000: 3604–3613. [Abstract] [Full Text] [PDF]
	Prospective Validation of Renal Function–Based Carboplatin Dosing in Children With Cancer: A United Kingdom Children’s Cancer Study Group Trial
	Huw Thomas, Alan V. Boddy, Martin W. English, Rachel Hobson, John Imeson, Ian Lewis, Bruce Morland, Andrew D. J. Pearson, Ross Pinkerton, Lisa Price, Michael Stevens, and David R. Newell
	JCO Nov 1 2000: 3614–3621. [Abstract] [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	Durable Remission After Aggressive Chemotherapy for Very Late Post–Kidney Transplant Lymphoproliferation: A Report of 16 Cases Observed in a Single Center
	M-F. Mamzer-Bruneel, C. Lomé, E. Morelon, V. Levy, P. Bourquelot, F. Jacobs, A. Gessain, E. Mac Intyre, N. Brousse, H. Kreis, and O. Hermine
	JCO Nov 1 2000: 3622–3632. [Abstract] [Full Text] [PDF]
	Role of a Doxorubicin-Containing Regimen in Relapsed and Resistant Lymphomas: An 8-Year Follow-Up Study of EPOCH
	Martin Gutierrez, Bruce A. Chabner, Debra Pearson, Seth M. Steinberg, Elaine S. Jaffe, Bruce D. Cheson, Antonio Fojo, and Wyndham H. Wilson
	JCO Nov 1 2000: 3633–3642. [Abstract] [Full Text] [PDF]

SARCOMAS
	High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation for Advanced Soft Tissue Sarcoma in Adults
	J-Y. Blay, D. Bouhour, I. Ray-Coquard, C. Dumontet, T. Philip, and P. Biron
	JCO Nov 1 2000: 3643–3650. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry
	Giovanni Pauletti, Suganda Dandekar, HongMei Rong, Lilllian Ramos, HongJun Peng, Ram Seshadri, and Dennis J. Slamon
	JCO Nov 1 2000: 3651–3664. [Abstract] [Full Text] [PDF]

CANCER RELATED COMPLICATIONS
	Physician Compliance With Warfarin Prophylaxis for Central Venous Catheters in Patients With Solid Tumors
	Karen M. Carr and Ian Rabinowitz
	JCO Nov 1 2000: 3665–3667. [Abstract] [Full Text] [PDF]

EPIDEMIOLOGY
	Dietary Fat Intake and Endogenous Sex Steroid Hormone Levels in Postmenopausal Women
	Michelle D. Holmes, Donna Spiegelman, Walter C. Willett, JoAnn E. Manson, David J. Hunter, Robert L. Barbieri, Graham A. Colditz, and Susan E. Hankinson
	JCO Nov 1 2000: 3668–3676. [Abstract] [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	Phase I Dose-Finding and Pharmacokinetic Study of Paclitaxel and Carboplatin With Oral Valspodar in Patients With Advanced Solid Tumors
	Amita Patnaik, Ellen Warner, Michael Michael, Merrill J. Egorin, Malcolm J. Moore, Lillian L. Siu, Paula M. Fracasso, Saul Rivkin, Ian Kerr, Manuel Litchman, and Amit M. Oza
	JCO Nov 1 2000: 3677–3689. [Abstract] [Full Text] [PDF]

SUPPORTIVE CARE AND QUALITY OF LIFE
	Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial
	Ronald Feld, Ben DePauw, Steven Berman, Armand Keating, and Winston Ho
	JCO Nov 1 2000: 3690–3698. [Abstract] [Full Text] [PDF]
	Time to Clinical Response: An Outcome of Antibiotic Therapy of Febrile Neutropenia With Implications for Quality and Cost of Care
	Linda S. Elting, Edward B. Rubenstein, Kenneth Rolston, Scott B. Cantor, Charles G. Martin, Danna Kurtin, Saul Rodriguez, Tony Lam, Krishnakumari Kanesan, and Gerald Bodey
	JCO Nov 1 2000: 3699–3706. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Molecular Biology of Burkitt’s Lymphoma
	Jonathan L. Hecht and Jon C. Aster
	JCO Nov 1 2000: 3707–3721. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Second-Line Chemotherapy in Relapsing or Refractory Non–Small-Cell Lung Cancer: A Review
	C. Huisman, E. F. Smit, G. Giaccone, and P. E. Postmus
	JCO Nov 1 2000: 3722–3730. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Two Unusual Lymphomas : Case 1: Primary Malignant Lymphoma (Diffuse Large B-Cell Lymphoma) of the Spleen Mimicking Splenic Abscess

S. Abraksia, P. Dileep Kumar, and Jan Kasal

JCO Nov 1 2000: 3731–3733. [Full Text] [PDF]

Two Unusual Lymphomas : Case 2: Pulmonary Intravascular Lymphomatosis

C. S. Chim, C. Choy, G. C. Ooi, L. P. Chung, K. K. Wong, and R. Liang

JCO Nov 1 2000: 3733–3735. [Full Text] [PDF]

ART OF ONCOLOGY

Submitting to Autonomy

David P. Steensma

JCO Nov 1 2000: 3736–3737. [Full Text] [PDF]

CORRESPONDENCE

Docetaxel as Second-Line Chemotherapy for Non–Small-Cell Lung Cancer

Fausto Roila, Albano Del Favero, Enzo Ballatori, Frances A. Shepherd, Luz Hammershaimb, and Yong S. Kim

JCO Nov 1 2000: 3738–3739. [Full Text] [PDF]

Correspondence Re: "Doc, Shouldn’t We Be Getting Some Tests?"

Bernard Bernhardt, Daniel Hayes, Charles L. Loprinzi, and Thomas J. Smith

JCO Nov 1 2000: 3739–3741. [Full Text] [PDF]

Cyclophosphamide and Etoposide for Pediatric Solid Tumors

Sheri L. Spunt, Alberto S. Pappo, and Naomi J. Winick

JCO Nov 1 2000: 3741–3743. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.